Correlation Between Atea Pharmaceuticals and Replimune
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Replimune Group, you can compare the effects of market volatilities on Atea Pharmaceuticals and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Replimune.
Diversification Opportunities for Atea Pharmaceuticals and Replimune
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Atea and Replimune is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Replimune go up and down completely randomly.
Pair Corralation between Atea Pharmaceuticals and Replimune
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to generate 0.47 times more return on investment than Replimune. However, Atea Pharmaceuticals is 2.12 times less risky than Replimune. It trades about 0.19 of its potential returns per unit of risk. Replimune Group is currently generating about -0.18 per unit of risk. If you would invest 310.00 in Atea Pharmaceuticals on October 15, 2024 and sell it today you would earn a total of 17.00 from holding Atea Pharmaceuticals or generate 5.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Atea Pharmaceuticals vs. Replimune Group
Performance |
| Timeline |
| Atea Pharmaceuticals |
| Replimune Group |
Atea Pharmaceuticals and Replimune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atea Pharmaceuticals and Replimune
The main advantage of trading using opposite Atea Pharmaceuticals and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |